ACTRN12614001143617
Recruiting
未知
Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients before and after treatment and for early detection screening using ISET (Isolation by Size of Epithelial/ Trophoblastic Tumour Cells) technology
Dr Karin Ried0 sites2,000 target enrollmentOctober 29, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Karin Ried
- Enrollment
- 2000
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •treatment effectiveness: Patient diagnosed with cancer;
- •Have previously received (at least 3 weeks ago) or will receive treatment within one week;
- •treatment may include chemotherapy, radiotherapy, hyperthermia, intravenous Vitamin C, or other complementary treatment as prescribed by the treating physician;
- •Early detection screening: Patients with a family history of cancer or patients with chronic disease, or as part of a health check
Exclusion Criteria
- •no exclusion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Effectiveness of monitoring levels of Circulating Tumour Cells (CTCs) in blood for early detection and treatment monitoring in cancer patients.CancerACTRN12617001496303Survon Pte Ltd300
Completed
Not Applicable
Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancerProstate cancerJPRN-UMIN000010410Department of Urology, Kobe university graduate school of medicine50
Recruiting
Not Applicable
Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancerJPRN-UMIN000024302Osaka University Graduate School of Medicine500
Recruiting
Not Applicable
Cytology-based Circulating Tumour Cell (CTC) Testing in cancer patients and for early detection screening: The ISET-CTC studyACTRN12620000986976AProf Dr Karin Ried5,000
Completed
Not Applicable
Observational study in hepatocellular carcinoma (Liver Disease)Health Condition 1: null- HepatoCellular CarcinomaHealth Condition 2: K746- Other and unspecified cirrhosis ofliverCTRI/2018/02/011987Institute of liver and Biliary Sciences53